Foster Corporation announced it ranked in Deloitte’s Technology Fast 500™, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. Foster Corporation grew 145% percent from 2008 to 2012.
Foster Polymer Distribution, a business unit of Foster Corporation has added Arkema Kynar® Rx 752 to its growing portfolio of medical grade polymers. This unique PVDF copolymer is USP Class VI compliant, chemical and autoclave resistant and can be processed using standard extrusion and injection molding equipment.
The annual Foster Golf Classic took place on Friday August 23rd at the Connecticut National Golf Club in Putnam, CT. The event gathered more than 65 employees, friends and customers for a Florida Scramble tournament in support of the American Diabetes Association. The event raised $2,357 for the cause. The Foster Family would like to thank all those that participated and we are looking forward to another successful event next year!
On August 10th 2013, members of the Foster Family participated in the 24th Annual Deary Memorial Road Race, sponsored by Day Kimball Heathcare. Each year, members of the Putnam, CT community walk, run and ride in support of the Deary Memorial Cancer Fund. Since inception in 1990, more than $1,000,000 has been raised to provide preventive care and cancer related services to individuals in our community.
Foster Corporation, a leader in custom polymers for medical devices, introduces ProPell™ thermoplastic polyurethane (TPU) and polyether block amide (PEBA) compounds for improved manufacturing and handling of medical catheters. These new compounds dramatically reduce tackiness and friction in soft, flexible polymers while maintaining other physical properties of the unmodified polymers.
Arkema Inc. recently introduced Rilsan® Clear G-170 MED, as a fully transparent polyamide for use in breathing masks, tubing and other transparent medical components. Rilsan® Clear G-170 MED is more transparent than glass and is 12% lighter than polycarbonate. In addition, Rilsan® Clear G-170 MED has a flexural modulus of 2,020 MPa (293,000 psi), representing a 16% improvement in flexibility compared to polycarbonate. These properties are necessary in those applications where patient comfort is required.
Foster Corporation now offers nano-reinforced composites for minimally invasive devices, such as catheters, with reinforcement loadings up to 30% by weight. Nano-reinforced compounds with high filler loadings provide substantial increase in physical properties of the base resin while maintaining processibility in thin wall components. Foster’s range of nano-reinforced compounds include nylons, TPEs and thermoplastic polyurethanes (TPUs).
Bill Blasius, Manager of Polymer Science at Foster Corporation recently participated in a Webinar Series with Hantel Technolgies to discuss the role of a custom compounder in medical device manufacturing. Webinar topics included an introduction to Foster Corporation, a background on Arkema Pebax® Polyamide Elastomers, a briefing of radiopacified polymers for catheter applications, a summary of nanocomposite compounds including properties & processes and finally a formulators perspective on device design possibilies.
Foster Corporation is actively seeking individuals to join our growing team. Current employment opportuntiies for our Connecticut facility include Project Manager (Pharmacuetical Division), Production Manager/Extrusion Engineer, Extrusion Operator and Senior Electro-Mechanical Technician. We are also looking for a Senior Electro-Mechanical Technician for the North Las Vegas plant.
As of February 5, Arkema has lifted the Force Majeure for Pebax elastomers. The Force Majeure was declared on April 6, 2012, following an explosion at the Evonik manufacuring plant in Marl Germany, which resulted in a sudden shortage of materials. Arkema & Foster are pleased to announce the end of the shortage and return of a normal and healthy supply chain.
- 1 of 2